The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British Journal of Pharmacology

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.1994.tb14842.xPMID 8032628PMCID PMC1910123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts.

  1994cited by this paper
• Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.

  1993cited by this paper
• Opposite Age‐Dependent Changes of α2A‐Adrenoceptors and Nonadrenoceptor [3H]Idazoxan Binding Sites (I2‐Imidazoline Sites) in the Human Brain: Strong Correlation of I2 with Monoamine Oxidase‐B Sites

  1993cited by this paper
• Analysis of a Segment of the Human Glial Fibrillary Acidic Protein Gene That Directs Astrocyte‐Specific Transcription

  1993cited by this paper
• Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type.

  1993cited by this paper
• Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.

  1993cited by this paper
• Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla.

  1993cited by this paper
• Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes

  1993cited by this paper
• Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.

  1993cited by this paper
• Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease.

  1993cited by this paper
• Expression of non‐adrenergic imidazoline sites in rat cerebral cortical astrocytes

  1993cited by this paper
• Differential Effects of the Alkylating Agent N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline on Brain α2‐Adrenoceptors and I2‐Imidazoline Sites In Vitro and In Vivo

  1993cited by this paper
• In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules.

  1992cited by this paper
• Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain

  1992cited by this paper
• In vivo activated brain astrocytes may produce and secrete nerve growth factor -like molecules

  1992cited by this paper
• Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain

  1992cited by this paper
• Keeping an eye on the I site: imidazoline-preferring receptors.

  1992cited by this paper
• Glial fibrillary acidic protein immunoreactivity following cortical devascularizing lesion.

  1992cited by this paper
• Quantitative aspects of reactive gliosis: A review

  1992cited by this paper
• Keeping an eye on the I site: imidazoline-prefemng receptors

  1992cited by this paper
• A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors

  1992cited by this paper
• Astroglia in Alzheimer's disease.

  1992cited by this paper
• Reduction in Focal Cerebral Ischemia by Agents Acting at Imidazole Receptors

  1992cited by this paper
• Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus.

  1992cited by this paper
• The evidence for astrocytes as a target for central noradrenergic activity: expression of adrenergic receptors.

  1992cited by this paper
• Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.

  1992cited by this paper
• Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells.

  1991cited by this paper
• Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain.

  1991cited by this paper
• The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain.

  1991cited by this paper
• Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex.

  1991cited by this paper
• Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane.

  1991cited by this paper
• Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance.

  1990cited by this paper
• Imidazoline receptors in rat liver cells: A novel receptor or a subtype of α2-adrenoceptors?

  1990cited by this paper
• Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?

  1990cited by this paper
• [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes

  1989cited by this paper
• Are there multiple imidazoline binding sites?

  1989cited by this paper
• [3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.

  1989cited by this paper
• Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem.

  1988cited by this paper
• N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function.

  1988cited by this paper
• Glial Fibrillary Acidic Protein Increases in the Spinal Cord of Lewis Rats with Acute Experimental Autoimmune Encephalomyelitis

  1988cited by this paper
• Functional receptors for neurotransmitters on astroglial cells.

  1987cited by this paper
• Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.

  1985cited by this paper
• Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

  1985cited by this paper
• Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.

  1984cited by this paper
• Bulk Preparation of CNS Cytoskeleton and the Separation of Individual Neurofilament Proteins by Gel Filtration: Dye‐Binding Characteristics and Amino Acid Compositions

  1982cited by this paper
• Glial fibrillary acidic protein and Alzheimer‐type senile dementia

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• An acidic protein isolated from fibrous astrocytes.

  1971cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study

  2025cites this paper
• A Key Mediator and Imaging Target in Alzheimer’s Disease: Unlocking the Role of Reactive Astrogliosis Through MAOB

  2024cites this paper
• Recent developments and challenges in positron emission tomography imaging of gliosis in chronic neuropathic pain.

  2024cites this paper
• Imidazoline-I2 PET Tracers in Neuroimaging

  2023cites this paper
• Glial Dysfunction in Substance Use Disorders. New insights from PET and MR Imaging

  2023cites this paper
• Imaging of Reactive Astrogliosis by Positron Emission Tomography

  2022cites this paper
• Astrocytes in the initiation and progression of epilepsy

  2022cites this paper
• I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice

  2022cites this paper
• 1 Title : Imaging transcriptomics : Convergent cellular , transcriptomic , and molecular neuroimaging signatures in the healthy adult human brain

  2021cites this paper
• Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

  2021cites this paper
• Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease

  2021cites this paper
• Title: Imaging transcriptomics: Convergent cellular, transcriptomic, and molecular neuroimaging signatures in the healthy adult human brain

  2021cites this paper
• Imaging transcriptomics: Convergent cellular, transcriptomic, and molecular neuroimaging signatures in the healthy adult human brain

  2021cites this paper
• Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?

  2021cites this paper
• Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain

  2021cites this paper
• Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease

  2020influential citation
• Disease‐modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil

  2020cites this paper
• Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

  2020cites this paper
• Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease

  2019cites this paper
• Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease.

  2018cites this paper
• Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO

  2018cites this paper
• First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site

  2018cites this paper
• Evaluation of 11 C-BU99008, a positron emission tomography ligand for the Imidazoline 2 binding site in human brain

  2018cites this paper
• Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

  2018cites this paper
• Molecular Imaging in Huntington's Disease.

  2018cites this paper
• Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs

  2015cites this paper
• Brain Protection Conferred by Long-Term Administration of 2-(2-Benzofuranyl)-2-Imidazoline Against Experimental Autoimmune Encephalomyelitis

  2015cites this paper
• Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human Brain

  2014cites this paper
• Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Sites in Rhesus Brain

  2014cites this paper
• Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain

  2013cites this paper
• Evaluation of 11 C-BU99008, a Positron Emission Tomography ligand for the Imidazoline 2 binding sites in Rhesus brain

  2013cites this paper
• Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of

  2012cites this paper
• Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of Neural Stem Cells*

  2012cites this paper
• Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2‐(4,5‐Dihydro‐1H‐imidazol‐2‐yl)‐1‐ methyl‐1H‐indole), for the imidazoline2 binding site

  2012cites this paper
• Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.

  2009cites this paper
• Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2-imidazoline, a high selectivity ligand for imidazoline I2 receptors

  2009cites this paper
• Identification of the Central Imidazoline Receptor Subtype Involved in Modulation of Halothane-Epinephrine Arrhythmias in Rats

  2005cites this paper
• Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.

  2005cites this paper
• Opposite changes in imidazoline I2 receptors and alpha2-adrenoceptors density in rat frontal cortex after induced gliosis.

  2005cites this paper
• Imidazoline I2 receptor density increases with the malignancy of human gliomas

  2004cites this paper
• Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites.

  2004cites this paper
• Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I2-site ligand 2-BFI.

  2003cites this paper
• Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

  2001cites this paper
• Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101

  2000cites this paper
• Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.

  1999cites this paper
• Pharmacologic and Molecular Discrimination of I2‐Imidazoline Receptor Subtypes a

  1999cites this paper
• Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts).

  1999cites this paper
• Inhibition of astroglial nitric oxide synthase type 2 expression by idazoxan.

  1999cites this paper
• Inhibition of Astroglial Nitric Oxide Synthase Type 2 Expression

  1999cites this paper
• Identification of I1 and I2 Imidazoline Receptors in Striatum Membranes from Different Speciesa

  1999cites this paper
• Imidazoline Receptors and Human Brain Disorders a

  1999cites this paper
• Attenuation of Tolerance to Opioid‐Induced Antinociception by Idazoxan and Other I2‐Ligands a

  1999cites this paper
• Imidazoline receptor proteins in brains of patients with Alzheimer's disease.

  1998cites this paper
• Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands

  1998cites this paper
• Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models.

  1998cites this paper
• Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.

  1998cites this paper
• Immunocytochemical localization of an imidazoline receptor protein in the central nervous system.

  1998cites this paper
• SHORT COMMUNICATION EFFECTS OF α2‐ADRENOCEPTOR ANTAGONISTS AND IMIDAZOLINE2‐RECEPTOR LIGANDS ON NEURONAL DAMAGE IN GLOBAL ISCHAEMIA IN THE RAT

  1997cites this paper
• Central imidazoline (I1) receptors as targets of centrally acting antihypertensives : moxonidine and rilmenidine

  1997cites this paper
• Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat.

  1997cites this paper
• Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine

  1997cites this paper
• Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes

  1997cites this paper
• Increased density of I2-imidazoline receptors in human glioblastomas.

  1996cites this paper
• Imidazoline receptors and their endogenous ligands.

  1996cites this paper
• Decreased density of I2- imidazoline receptors in the postmortem brains of heroin addicts

  1996cites this paper
• Identification and characterization of imidazoline-binding sites from calf striatum.

  1996cites this paper
• Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims.

  1996cites this paper
• Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non‐adrenoceptor [3H]‐idazoxan binding sites

  1996cites this paper
• Intermediate filament proteins.

  1995cites this paper
• I2‐Imidazoline Receptors in the Healthy and Pathologic Human Brain fn1

  1995cites this paper
• Chronic Treatment with Phenelzine and Other Irreversible Monoamine Oxidase Inhibitors Downregulates I2‐Imidazoline Receptors in the Brain and Liver fn1

  1995cites this paper
• Alpha 2-adrenoceptors and I2 sites in the mammalian central nervous system.

  1995cites this paper
• Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes

  1995cites this paper
• Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.

  1995cites this paper
• Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain.

  1995cites this paper
• The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline‐preferring receptors

  1995cites this paper
• Theeffects ofphenelzine andother monoamine oxidase inhibitor antidepressants onbrain andliver 12 imidazoline-pref erring receptors

  1995cites this paper
• LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.

  1995cites this paper
• Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues.

  1994cites this paper
• Opus: University of Bath Online Publication Store Evaluation of 11 C-bu99008, a Positron Emission Tomography Ligand for the Imidazoline 2 Binding Sites in Rhesus Brain

  year unknowncites this paper